/ Side by side
Sermorelin vs Tesamorelin
A neutral, side-by-side look at Sermorelin and Tesamorelin: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Sermorelin
Geref · GHRH 1-29
Full profile →Tesamorelin
Egrifta
Full profile →| Attribute | Sermorelin | Tesamorelin |
|---|---|---|
| Category | Growth Hormone | GLP-1 / Metabolic |
| Half-life | ~10-20 min | ~26-38 min, subcutaneous |
| Common vial | 5, 10 mg | 5, 10 mg |
| Reference | Verified | Verified |
What is Sermorelin?
A synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone that binds pituitary GHRH receptors to stimulate endogenous growth hormone secretion. Previously marketed (Geref) and used in diagnostic testing.
Sources
- FDA history: Geref
What is Tesamorelin?
A stabilized growth-hormone-releasing hormone (GHRH) analog that binds pituitary GHRH receptors to stimulate endogenous growth hormone secretion. FDA-approved (Egrifta) to reduce excess visceral abdominal fat in HIV-associated lipodystrophy.
Sources
- FDA label: Egrifta (2010)
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.